These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Obesity-induced cardiac lipid accumulation in adult mice is modulated by G protein-coupled receptor kinase 2 levels. Lucas E; Vila-Bedmar R; Arcones AC; Cruces-Sande M; Cachofeiro V; Mayor F; Murga C Cardiovasc Diabetol; 2016 Nov; 15(1):155. PubMed ID: 27832814 [TBL] [Abstract][Full Text] [Related]
5. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy. Tang X; Chen XF; Wang NY; Wang XM; Liang ST; Zheng W; Lu YB; Zhao X; Hao DL; Zhang ZQ; Zou MH; Liu DP; Chen HZ Circulation; 2017 Nov; 136(21):2051-2067. PubMed ID: 28947430 [TBL] [Abstract][Full Text] [Related]
6. Knockout of p21-activated kinase-1 attenuates exercise-induced cardiac remodelling through altered calcineurin signalling. Davis RT; Simon JN; Utter M; Mungai P; Alvarez MG; Chowdhury SA; Heydemann A; Ke Y; Wolska BM; Solaro RJ Cardiovasc Res; 2015 Dec; 108(3):335-47. PubMed ID: 26464331 [TBL] [Abstract][Full Text] [Related]
7. Constitutive glycogen synthase kinase-3alpha/beta activity protects against chronic beta-adrenergic remodelling of the heart. Webb IG; Nishino Y; Clark JE; Murdoch C; Walker SJ; Makowski MR; Botnar RM; Redwood SR; Shah AM; Marber MS Cardiovasc Res; 2010 Aug; 87(3):494-503. PubMed ID: 20299330 [TBL] [Abstract][Full Text] [Related]
8. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure. Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-200a-3p Is a Positive Regulator in Cardiac Hypertrophy Through Directly Targeting WDR1 as Well as Modulating PTEN/PI3K/AKT/CREB/WDR1 Signaling. Yang X; Chen G; Chen Z J Cardiovasc Pharmacol; 2019 Nov; 74(5):453-461. PubMed ID: 31651553 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-96 promotes myocardial hypertrophy by targeting mTOR. Sun X; Zhang C Int J Clin Exp Pathol; 2015; 8(11):14500-6. PubMed ID: 26823769 [TBL] [Abstract][Full Text] [Related]
11. ADAMTS16 activates latent TGF-β, accentuating fibrosis and dysfunction of the pressure-overloaded heart. Yao Y; Hu C; Song Q; Li Y; Da X; Yu Y; Li H; Clark IM; Chen Q; Wang QK Cardiovasc Res; 2020 Apr; 116(5):956-969. PubMed ID: 31297506 [TBL] [Abstract][Full Text] [Related]
13. mTOR, cardiomyocytes and inflammation in cardiac hypertrophy. Xu L; Brink M Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1894-903. PubMed ID: 26775585 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic response to environmental stress: Assembly of BRG1-G9a/GLP-DNMT3 repressive chromatin complex on Myh6 promoter in pathologically stressed hearts. Han P; Li W; Yang J; Shang C; Lin CH; Cheng W; Hang CT; Cheng HL; Chen CH; Wong J; Xiong Y; Zhao M; Drakos SG; Ghetti A; Li DY; Bernstein D; Chen HS; Quertermous T; Chang CP Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1772-81. PubMed ID: 26952936 [TBL] [Abstract][Full Text] [Related]
15. Phenotyping an adult zebrafish lamp2 cardiomyopathy model identifies mTOR inhibition as a candidate therapy. Dvornikov AV; Wang M; Yang J; Zhu P; Le T; Lin X; Cao H; Xu X J Mol Cell Cardiol; 2019 Aug; 133():199-208. PubMed ID: 31228518 [TBL] [Abstract][Full Text] [Related]
16. Proteasome inhibition in hypertrophied myocardium. Friehs I Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1373-4. PubMed ID: 18708439 [No Abstract] [Full Text] [Related]
18. Cardiac energy dependence on glucose increases metabolites related to glutathione and activates metabolic genes controlled by mechanistic target of rapamycin. Schisler JC; Grevengoed TJ; Pascual F; Cooper DE; Ellis JM; Paul DS; Willis MS; Patterson C; Jia W; Coleman RA J Am Heart Assoc; 2015 Feb; 4(2):. PubMed ID: 25713290 [TBL] [Abstract][Full Text] [Related]
19. Focal adhesion kinase governs cardiac concentric hypertrophic growth by activating the AKT and mTOR pathways. Clemente CF; Xavier-Neto J; Dalla Costa AP; Consonni SR; Antunes JE; Rocco SA; Pereira MB; Judice CC; Strauss B; Joazeiro PP; Matos-Souza JR; Franchini KG J Mol Cell Cardiol; 2012 Feb; 52(2):493-501. PubMed ID: 22056317 [TBL] [Abstract][Full Text] [Related]
20. Elucidating ERK2 function in the heart. Del Re DP; Sadoshima J J Mol Cell Cardiol; 2014 Jul; 72():336-8. PubMed ID: 24769140 [No Abstract] [Full Text] [Related] [Next] [New Search]